newsfilter
← Latest News
GlobeNewswire·

Cyclacel Pharmaceuticals Reports First Quarter Financial Results and Provides Business Update

- New Clinical Data to be Presented at ASCO Annual Meeting Highlighting Potential Precision Medicine Strategy with Oral Fadraciclib -- First Patients Enrolled in Oral Fadraciclib Phase 2 Proof of Concept Study -- Balance